Regulatory systems and requirements for clinical trials of AAV-based gene therapies – Perspectives from six Asian countries or regions: Report from the 6th Asia Partnership Conference of Regenerative Medicine – April 20, 2023

Regulatory systems and requirements for clinical trials of AAV-based gene therapies – Perspectives from six Asian countries or regions: Report from the 6th Asia Partnership Conference of Regenerative Medicine – April 20, 2023

Gene therapies, which include viral-vector gene delivery, genome editing, and genetically modified cell therapy, are innovative treatments with the potential to address the underlying genetic causes of disorders and to provide life-changing value in terms of curing disease. Although adeno-associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Hirokuni Mizoguchi, Alex J. Zhang, Pawan Kumar Gupta, Masato Komuro, Wong Kum Cheun, Chuan Wen Chiu, Bryan Choi
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Regenerative Therapy
Subjects:
Gene therapy
AAV
Asia
Regulatory guidance
Regulatory consultation
Online Access:http://www.sciencedirect.com/science/article/pii/S2352320424001111
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2352320424001111

Similar Items